ASND Stock Summary

• The ratio of debt to operating expenses for Ascendis Pharma A is higher than it is for about merely 0.37% of US stocks.
• With a price/sales ratio of 487.8, Ascendis Pharma A has a higher such ratio than 99.3% of stocks in our set.
• In terms of twelve month growth in earnings before interest and taxes, Ascendis Pharma A is reporting a growth rate of 1,247.11%; that's higher than 98.93% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Ascendis Pharma A are PRNB, ACIU, MGNX, ARGX, and MRTX.
• ASND's SEC filings can be seen here. And to visit Ascendis Pharma A's official web site, go to www.ascendispharma.com.